Our diverse portfolio of regenerative medicine solutions is designed to improve the outcomes and quality of life of patients through three distinct solution therapy areas.
VIVEX is expanding our Amnion & Wound Care Distribution Network. Interested in becoming a distribution partner? Click here to learn more.
Our pioneering research has led to the development of advanced regenerative medicine solutions designed to improve the outcomes and quality of life for patients suffering from low back pain, musculoskeletal injuries, chronic wounds, burned and injured skin, and aging and degenerative joints.
Our products are regulated by the FDA and, to date, more than two million allografts have been distributed in the United States with zero cases of disease transmission reported.
From research and discovery to product design and clinical implementation, we strive to be a leader in allograft research and development, advancing the field of bone and soft tissue transplantation.
The VIVEX Difference
Integrity Processing™
Our solutions are manufactured utilizing our innovative Integrity Processing™ methodology, which focuses on protecting tissue from harmful cleaning agents, maintaining the natural state of tissue, and thus preserving the inherent characteristics of our allografts to support patients’ regenerative potential.
Every day, by utilizing VIVEX solutions, clinicians across the nation are able to help patients suffering from musculoskeletal injuries, chronic wounds, burned and injured skin, aging and degenerative joints, and chronic low back pain.
With a successful track record of delivering highly innovative, disruptive, new technologies to the market, we continue to have a pipeline of differentiated, novel technologies that we plan to launch in the coming years that will redefine the current paradigm of regenerative medicine.
